NSE · AI Signal & Stock Analysis · Neutral
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for NEPHROPLUS is Neutral → (mild move); technical trend down-trend; trading at ₹710.85 (+1.98% today); neutral (RSI 58).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | Down-trend (since 2025-12-17) |
| Price | ₹710.85 |
| Change today | +1.98% |
| RSI (14) | 57.70 |
| Relative volume | 0.88 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹6,778 Cr |
| P/E | 79.29 |
| Cap category | Mid Cap |
| 52-week high | -5.4% away |
| 52-week low | +58.3% above |
| Delivery volume | — |
| Sector | Medical Care Facilities |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for NEPHROPLUS (Nephrocare Health Services Limited) is Neutral with a mild move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
NEPHROPLUS's RSI is neutral (RSI 58). A reading above 70 is typically overbought and below 30 oversold.
NEPHROPLUS is trading about 5% below its 52-week high and 58% above its 52-week low as of Sep 28 2026, 6:47 PM.
NEPHROPLUS's market capitalisation is ₹6,778 Cr as of Sep 28 2026, 6:47 PM.
NEPHROPLUS is classified under Medical Care Facilities in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for NEPHROPLUS — not personalised investment advice. Always do your own research.
APOLLOHOSP · ASTERDM · FORTIS · HCG · JLHL · JSLL
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.